[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100611940":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":42,"centralContacts":46,"locations":52,"responsibleParty":291,"collaborators":30,"id":293,"slug":30,"hasResults":294,"nctId":295,"briefTitle":296,"officialTitle":297,"acronym":30,"eligibilityCriteria":298,"healthyVolunteers":294,"sex":299,"minAge":300,"maxAge":30,"enrollmentInfo":301,"targetDuration":30,"studyType":304,"phases":305,"briefSummary":307,"conditions":308,"keywords":30,"overallStatus":55,"whyStopped":30,"lastUpdateSubmitDate":310,"lastUpdatePostDateStruct":311,"startDateStruct":314,"completionDateStruct":316,"leadSponsor":318,"locationsCount":319},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",[8,14,19],{"label":9,"type":10,"description":11,"interventionNames":12},"MK-4716 Dose Escalation","EXPERIMENTAL","Participants receive MK-4716 at varying dose levels and schedules.",[13],"Drug: MK-4716",{"label":15,"type":10,"description":16,"interventionNames":17},"MK-4716 + Pembrolizumab","Participants will receive MK-4716 + Pembrolizumab",[13,18],"Biological: Pembrolizumab",{"label":20,"type":10,"description":21,"interventionNames":22},"MK-4716 + Cetuximab","Participants will receive MK-4716 + Cetuximab",[13,23],"Biological: Cetuximab",[25,31,39],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","MK-4716","Oral administration",[20,15,9],null,{"type":32,"name":33,"description":34,"armGroupLabels":35,"otherNames":36},"BIOLOGICAL","Pembrolizumab","Intravenous administration",[15],[37,38],"Keytruda","MK-3475",{"type":32,"name":40,"description":34,"armGroupLabels":41,"otherNames":30},"Cetuximab",[20],[43],{"name":44,"affiliation":5,"role":45},"Medical Director","STUDY_DIRECTOR",[47],{"name":48,"role":49,"phone":50,"phoneExt":30,"email":51},"Toll Free Number","CONTACT","1-888-577-8839","Trialsites@msd.com",[53,70,83,96,110,123,135,148,162,175,189,198,211,223,235,248,257,270,279],{"facility":54,"status":55,"city":56,"state":57,"zip":58,"country":59,"cosmosGeoPoint":60,"geoPoint":65,"contacts":66},"Rutgers Cancer Institute of New Jersey ( Site 0052)","RECRUITING","New Brunswick","New Jersey","08903","United States",{"type":61,"coordinates":62},"Point",[63,64],-74.45182,40.48622,{"lat":64,"lon":63},[67],{"name":68,"role":49,"phone":69,"phoneExt":30,"email":30},"Study Coordinator","732-253-3939",{"facility":71,"status":55,"city":72,"state":73,"zip":74,"country":59,"cosmosGeoPoint":75,"geoPoint":79,"contacts":80},"NEXT Oncology ( Site 0051)","Irving","Texas","75039",{"type":61,"coordinates":76},[77,78],-96.94889,32.81402,{"lat":78,"lon":77},[81],{"name":68,"role":49,"phone":82,"phoneExt":30,"email":30},"972-893-8800",{"facility":84,"status":55,"city":85,"state":86,"zip":87,"country":59,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"NEXT Virginia ( Site 0054)","Fairfax","Virginia","22031",{"type":61,"coordinates":89},[90,91],-77.30637,38.84622,{"lat":91,"lon":90},[94],{"name":68,"role":49,"phone":95,"phoneExt":30,"email":30},"703-783-4510",{"facility":97,"status":55,"city":98,"state":99,"zip":100,"country":101,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Blacktown Hospital ( Site 0455)","Sydney","New South Wales","2148","Australia",{"type":61,"coordinates":103},[104,105],151.20732,-33.86785,{"lat":105,"lon":104},[108],{"name":68,"role":49,"phone":109,"phoneExt":30,"email":30},"98818000",{"facility":111,"status":55,"city":112,"state":113,"zip":114,"country":101,"cosmosGeoPoint":115,"geoPoint":119,"contacts":120},"Monash Health ( Site 0452)","Clayton","Victoria","3168",{"type":61,"coordinates":116},[117,118],145.11667,-37.91667,{"lat":118,"lon":117},[121],{"name":68,"role":49,"phone":122,"phoneExt":30,"email":30},"+61474769510",{"facility":124,"status":55,"city":125,"state":113,"zip":126,"country":101,"cosmosGeoPoint":127,"geoPoint":131,"contacts":132},"The Alfred Hospital ( Site 0453)","Melbourne","3004",{"type":61,"coordinates":128},[129,130],144.96332,-37.814,{"lat":130,"lon":129},[133],{"name":68,"role":49,"phone":134,"phoneExt":30,"email":30},"+61 3 9076 3129",{"facility":136,"status":55,"city":137,"state":138,"zip":139,"country":101,"cosmosGeoPoint":140,"geoPoint":144,"contacts":145},"One Clinical Research ( Site 0454)","Nedlands","Western Australia","6009",{"type":61,"coordinates":141},[142,143],115.8073,-31.98184,{"lat":143,"lon":142},[146],{"name":68,"role":49,"phone":147,"phoneExt":30,"email":30},"+61862799466",{"facility":149,"status":55,"city":150,"state":151,"zip":152,"country":153,"cosmosGeoPoint":154,"geoPoint":158,"contacts":159},"Princess Margaret Cancer Centre ( Site 0001)","Toronto","Ontario","M5G 2M9","Canada",{"type":61,"coordinates":155},[156,157],-79.39864,43.70643,{"lat":157,"lon":156},[160],{"name":68,"role":49,"phone":161,"phoneExt":30,"email":30},"4165865371",{"facility":163,"status":55,"city":164,"state":165,"zip":166,"country":153,"cosmosGeoPoint":167,"geoPoint":171,"contacts":172},"Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0002)","Québec","Quebec","G1J 1Z4",{"type":61,"coordinates":168},[169,170],-71.21454,46.81228,{"lat":170,"lon":169},[173],{"name":68,"role":49,"phone":174,"phoneExt":30,"email":30},"418-525-4444",{"facility":176,"status":55,"city":177,"state":178,"zip":179,"country":180,"cosmosGeoPoint":181,"geoPoint":185,"contacts":186},"Pontificia Universidad Catolica de Chile-CICUC ( Site 0103)","Santiago","Region M. de Santiago","8330073","Chile",{"type":61,"coordinates":182},[183,184],-70.64827,-33.45694,{"lat":184,"lon":183},[187],{"name":68,"role":49,"phone":188,"phoneExt":30,"email":30},"+56934331806",{"facility":190,"status":55,"city":177,"state":178,"zip":191,"country":180,"cosmosGeoPoint":192,"geoPoint":194,"contacts":195},"Bradfordhill ( Site 0102)","8420383",{"type":61,"coordinates":193},[183,184],{"lat":184,"lon":183},[196],{"name":68,"role":49,"phone":197,"phoneExt":30,"email":30},"+56229490970",{"facility":199,"status":55,"city":200,"state":30,"zip":201,"country":202,"cosmosGeoPoint":203,"geoPoint":207,"contacts":208},"Rambam Health Care Campus ( Site 0252)","Haifa","3109601","Israel",{"type":61,"coordinates":204},[205,206],34.99928,32.81303,{"lat":206,"lon":205},[209],{"name":68,"role":49,"phone":210,"phoneExt":30,"email":30},"+97247772688",{"facility":212,"status":55,"city":213,"state":30,"zip":214,"country":202,"cosmosGeoPoint":215,"geoPoint":219,"contacts":220},"Rabin Medical Center ( Site 0253)","Petah Tikva","4941492",{"type":61,"coordinates":216},[217,218],34.88747,32.08707,{"lat":218,"lon":217},[221],{"name":68,"role":49,"phone":222,"phoneExt":30,"email":30},"+97239377377",{"facility":224,"status":55,"city":225,"state":30,"zip":226,"country":202,"cosmosGeoPoint":227,"geoPoint":231,"contacts":232},"Sheba Medical Center ( Site 0251)","Ramat Gan","5265601",{"type":61,"coordinates":228},[229,230],34.81065,32.08227,{"lat":230,"lon":229},[233],{"name":68,"role":49,"phone":234,"phoneExt":30,"email":30},"+97235303030",{"facility":236,"status":55,"city":237,"state":30,"zip":238,"country":239,"cosmosGeoPoint":240,"geoPoint":244,"contacts":245},"Seoul National University Hospital ( Site 0501)","Seoul","03080","South Korea",{"type":61,"coordinates":241},[242,243],126.9784,37.566,{"lat":243,"lon":242},[246],{"name":68,"role":49,"phone":247,"phoneExt":30,"email":30},"82-2-2072-0242",{"facility":249,"status":55,"city":237,"state":30,"zip":250,"country":239,"cosmosGeoPoint":251,"geoPoint":253,"contacts":254},"Asan Medical Center ( Site 0502)","05505",{"type":61,"coordinates":252},[242,243],{"lat":243,"lon":242},[255],{"name":68,"role":49,"phone":256,"phoneExt":30,"email":30},"82-2-3010-1727",{"facility":258,"status":55,"city":259,"state":30,"zip":260,"country":261,"cosmosGeoPoint":262,"geoPoint":266,"contacts":267},"Hospital General Universitari Vall d Hebron ( Site 0360)","Barcelona","08035","Spain",{"type":61,"coordinates":263},[264,265],2.15899,41.38879,{"lat":265,"lon":264},[268],{"name":68,"role":49,"phone":269,"phoneExt":30,"email":30},"+34932746000",{"facility":271,"status":55,"city":259,"state":30,"zip":272,"country":261,"cosmosGeoPoint":273,"geoPoint":275,"contacts":276},"Hospital Clinic de Barcelona ( Site 0362)","08036",{"type":61,"coordinates":274},[264,265],{"lat":265,"lon":264},[277],{"name":68,"role":49,"phone":278,"phoneExt":30,"email":30},"+34932274208",{"facility":280,"status":55,"city":281,"state":30,"zip":282,"country":261,"cosmosGeoPoint":283,"geoPoint":287,"contacts":288},"Hospital Universitario Fundacion Jimenez Diaz ( Site 0361)","Madrid","28040",{"type":61,"coordinates":284},[285,286],-3.70256,40.4165,{"lat":286,"lon":285},[289],{"name":68,"role":49,"phone":290,"phoneExt":30,"email":30},"+34915504800x2805",{"type":292,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100611940",false,"NCT07247110","A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)","A Phase 1, Open-Label, Multicenter Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of MK-4716 as Monotherapy and as Part of Combination Therapy in Participants With KRAS-Altered Advanced or Metastatic Solid Tumors","Inclusion Criteria:\n\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Has a confirmed diagnosis of locally advanced unresectable or metastatic solid tumor\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Must demonstrate presence of Kirsten rat sarcoma viral oncogene homolog (KRAS) alteration\n* Subset of arm MK-4716 Dose Escalation and subset of arm MK-4716 + Cetuximab: Has received at least 1 prior line of systemic therapy for locally advanced unresectable or metastatic disease\n* Arm MK-4716 + Pembrolizumab: Has a confirmed diagnosis of metastatic non-small cell lung cancer\n* Arm MK-4716 + Pembrolizumab: Must demonstrate presence of KRAS alteration\n* Arm MK-4716 + Pembrolizumab: Must be untreated\n* Has measurable disease\n* Has the ability to swallow and retain oral medication\n\nExclusion Criteria:\n\n* Arm MK-4716 + Pembrolizumab: Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior to the first dose of study intervention\n* Arm MK-4716 + Pembrolizumab: Has received any prior immunotherapy and was discontinued from that treatment\n* Arm MK-4716 + Pembrolizumab: Has active autoimmune disease that has required systemic treatment in the past 2 years. Hormonal supplementation (eg, thyroxine, insulin, or physiologic corticosteroid) is allowed\n* History of human immunodeficiency virus infection\n* Has a known additional malignancy that is progressing or has required active treatment within the past 2 years\n* Has a known active central nervous system metastases and\u002For carcinomatous meningitis\n* History of (noninfectious) pneumonitis\u002Finterstitial lung disease that required steroids or has current pneumonitis\u002Finterstitial lung disease\n* Has active infection requiring systemic therapy\n* Has Hepatitis B or Hepatitis C virus infection\n* History of stem cell\u002Fsolid organ transplant\n* Has not adequately recovered from major surgery or has ongoing surgical complications","ALL","18 Years",{"count":302,"type":303},250,"ESTIMATED","INTERVENTIONAL",[306],"PHASE1","Researchers are looking for new ways to treat certain advanced or metastatic solid tumors. The goal of this study is to learn about the safety of MK-4716 and if people tolerate it when taken alone or with other treatments.",[309],"Malignant Neoplasm","2026-06-01",{"date":312,"type":313},"2026-06-03","ACTUAL",{"date":315,"type":313},"2025-12-16",{"date":317,"type":303},"2030-12-01",{"name":5,"class":6},19]